19 December 2018

The Dutch Cancer Society (KWF) has awarded 8 grants to Radboudumc researchers. We congratulate them with this funding and wish them success with their great work.

Research project:

Research project: 177Lu-PSMA Radioligand Therapy for Salivary Gland Cancer.
Carla van Herpen, theme Rare cancers, RIHS
Approved budget: € 656,845

Young Investigator grant:

Research project: Fear of progression in advanced cancer patients with prolonged survival on ongoing cancer treatment in an era of personalized medicine.
Jose Custers, theme Women's cancers, RIHS
Approved budget: € 424,731

Consortium

Research project: Timely detection of breast cancer: the interplay of mammographical characteristics, growth rate and clinicopathological features in predicting the outcome.
Mireille Broeders, theme Women's cancers, RIHS
Approved budget: € 730,260

Unique high risk projects:

Research project: Boosting intraperitoneal NK cell therapy in ovarian cancer through mRNA mediated IL-15 expression.
Roland Brock, theme Nanomedicine, RIMLS.
Approved budget: € 116.502

Research project: PROACTING: Predicting neoadjuvant treatment response with deep learning.
Francesco Ciompi, theme Tumors of the digestive tract, RIHS
Approved budget: € 199,959

Research project: Development of a minimal invasive surgical treatment for skeletal metastases.
Ingrid van der Geest,  theme Reconstructive and regenerative medicine, RIHS
Approved budget: € 146,062

Research project: Correlation between CT perfusion, genomics and immunohistopathology to predict and evaluate therapy response in patients with pancreatic ductal adenocarcinoma.
John Hermans, theme Rare cancers, RIHS
Approved budget: € 229,405

Infractructural initiative

Research project: COMPRAYA: Landelijke infrastructuur om gezondheidsuitkomsten in kaart te brengen en interventiestudies uit te voeren onder jongvolwassenen met kanker (AYA's).
Winette van der Graaf, theme Rare cancers, RIHS
Approved budget: € 2,790,721

Go to the Dutch Cancer Society website (KWF).

Related news items


Surprisingly dominant cause underlying type I congenital defect of glycosylation

21 October 2021

Alex Garanto, Melissa Bärenfänger, Mirian Janssen, and Dirk Lefeber published a new study, identifying a surprisingly dominant genetic cause underlying type I congenital defect of glycosylation with neuromusculoskeletal phenotypes.

read more

Sensitive blood-test as a patient-friendly alternative for bone marrow-based cancer monitoring

20 October 2021

Hans Jacobs and Pieter Langerhorst, theme Cancer development and immune defense, and colleagues are one step closer to implementation of personalized diagnostics for bone marrow-based cancer monitoring.

read more

Register for peer coaching for RIMLS PhD candidates

20 October 2021

As a PhD candidate, you are in the lead of your own learning process, but you don’t need to do this alone. Register for the peer-coaching group ‘Stay in the lead – Together’ before 11 November 2021.

read more

Frans Russel appointed member Supervisory Committee of RIVM

20 October 2021

Frans Russel, theme Renal disorders, has been appointed by The Minister of Health, Welfare and Sport (VWS).

read more

Turbo Grants for four medical-technical research projects

19 October 2021

Four TURBO grants were recently awarded to new technical-medical research proposals. The grants are part of the TURBO program, a collaboration between the University of Twente (TechMed Centre) and the Radboudumc.

read more